CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 14, 2018

Study Completion Date

May 14, 2018

Conditions
Insomnia
Interventions
BEHAVIORAL

CBTI-CS

CBTI-CS is a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia. Cognitive factors are addressed via cognitive restructuring and psychoeducation. Behavioral factors are addressed by structured sleep restriction, stimulus control and sleep hygiene techniques. Cancer treatment late-effects affecting sleep are addressed as potential contributors to these cognitive and behavioral factors, and as symptoms that may benefit from referral for medical evaluation/management. Participants are instructed in these cognitive-behavioral strategies as a group, but using analysis of personal sleep-log data, symptom self-reports and targeted workbook exercises, they are helped to tailor the intervention to address their specific needs.

BEHAVIORAL

Sleep Hygiene

Education on health behaviors, sleep habits and environmental practices intended to promote good quality sleep. Recommendations target exercise and natural light exposure,use of stimulants and alcohol, daytime napping, timing of meals, creating a comfortable non-stimulating sleep space, and creating sleep rituals.

BEHAVIORAL

CBTI-CS via Telehealth

The CBTI-CS intervention, a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia, will be administered via live video. conferencing. Participants will have a single in-person training session and subsequent CBTI-CS group sessions will be conducted by live video conference.

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT02756390 - CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | Biotech Hunter | Biotech Hunter